Pfizer, Flynn appeal against UK regulator’s £89.4m fine for epilepsy drug price hike
Pfizer has been fined £84.2m and Flynn Pharma £5.2m after they increased prices by as much as 2,600% in September 2012. The companies have separately filed appeals in the Competition Appeal
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.